Johnson & Johnson appoints Yale project team to run data sharing schemeBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g1361 (Published 05 February 2014) Cite this as: BMJ 2014;348:g1361
- Zosia Kmietowicz
Johnson & Johnson has appointed an independent US body to field requests from researchers for access to its clinical trials data.
Janssen, the pharmaceutical arm of Johnson & Johnson, has entered into an agreement with the Yale University Open Data Access (YODA) project at the Yale School of Medicine in New Haven, Connecticut. The YODA team will make final decisions about all requests for sharing data, including clinical study reports and de-identified patient level data.
Joanne Waldstreicher, chief medical officer at Johnson & Johnson, said in a statement, “We are pleased to collaborate with YODA to ensure that each and every request for access to our pharmaceutical clinical data is reviewed objectively and independently. This represents a …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial